NAMS
Price
$18.39
Change
-$2.08 (-10.16%)
Updated
Apr 1, 04:59 PM (EDT)
Capitalization
2.02B
35 days until earnings call
QURE
Price
$9.91
Change
-$0.69 (-6.51%)
Updated
Apr 1 closing price
Capitalization
535.9M
41 days until earnings call
Ad is loading...

NAMS vs QURE

Header iconNAMS vs QURE Comparison
Open Charts NAMS vs QUREBanner chart's image
NewAmsterdam Pharma
Price$18.39
Change-$2.08 (-10.16%)
Volume$47.8K
Capitalization2.02B
uniQure
Price$9.91
Change-$0.69 (-6.51%)
Volume$2.08M
Capitalization535.9M
NAMS vs QURE Comparison Chart
Loading...
NAMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NAMS vs. QURE commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAMS is a StrongBuy and QURE is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (NAMS: $20.47 vs. QURE: $10.60)
Brand notoriety: NAMS and QURE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NAMS: 157% vs. QURE: 372%
Market capitalization -- NAMS: $2.02B vs. QURE: $535.9M
NAMS [@Biotechnology] is valued at $2.02B. QURE’s [@Biotechnology] market capitalization is $535.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NAMS’s FA Score shows that 1 FA rating(s) are green whileQURE’s FA Score has 0 green FA rating(s).

  • NAMS’s FA Score: 1 green, 4 red.
  • QURE’s FA Score: 0 green, 5 red.
According to our system of comparison, NAMS is a better buy in the long-term than QURE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NAMS’s TA Score shows that 6 TA indicator(s) are bullish while QURE’s TA Score has 4 bullish TA indicator(s).

  • NAMS’s TA Score: 6 bullish, 4 bearish.
  • QURE’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, NAMS is a better buy in the short-term than QURE.

Price Growth

NAMS (@Biotechnology) experienced а -14.71% price change this week, while QURE (@Biotechnology) price change was -28.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.07%. For the same industry, the average monthly price growth was -13.26%, and the average quarterly price growth was -12.25%.

Reported Earning Dates

NAMS is expected to report earnings on May 07, 2025.

QURE is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-9.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NAMS($2.02B) has a higher market cap than QURE($536M). NAMS YTD gains are higher at: -20.350 vs. QURE (-39.977). QURE has higher annual earnings (EBITDA): -160.74M vs. NAMS (-241.49M). NAMS has more cash in the bank: 834M vs. QURE (368M). NAMS has less debt than QURE: NAMS (448K) vs QURE (66.1M). NAMS has higher revenues than QURE: NAMS (45.6M) vs QURE (27.1M).
NAMSQURENAMS / QURE
Capitalization2.02B536M376%
EBITDA-241.49M-160.74M150%
Gain YTD-20.350-39.97751%
P/E RatioN/AN/A-
Revenue45.6M27.1M168%
Total Cash834M368M227%
Total Debt448K66.1M1%
FUNDAMENTALS RATINGS
QURE: Fundamental Ratings
QURE
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
90
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NAMSQURE
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 5 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
40%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
40%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 20 days ago
71%
Bullish Trend 16 days ago
75%
Declines
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
NAMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BBISX30.66N/A
N/A
Sterling Capital Behav Lg Cp Val Eq Intl
NBFCX29.49N/A
N/A
Neuberger Berman Focus Trust
FTHNX41.32N/A
N/A
FullerThaler Behavioral Sm-Cp Eq Inv
DIEZX11.51N/A
N/A
Destinations International Equity Z
FIJGX58.36N/A
N/A
Fidelity Advisor Telecommunications Z

NAMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAMS has been loosely correlated with CMRX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if NAMS jumps, then CMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAMS
1D Price
Change %
NAMS100%
-5.93%
CMRX - NAMS
51%
Loosely correlated
+0.12%
QURE - NAMS
50%
Loosely correlated
-15.00%
CRDF - NAMS
34%
Loosely correlated
-4.56%
GYRE - NAMS
32%
Poorly correlated
-15.26%
IMCR - NAMS
28%
Poorly correlated
+0.30%
More